Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-06 Sale |
2025-02-10 6:04 pm |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
10,000 | $22 | $220,000 | 31,000 (Direct) |
View |
| 2025-01-23 Sale |
2025-01-23 8:36 pm |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
16,000 | $20 | $320,000 | 31,000 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-15 9:50 pm |
Natera Inc. | NTRA | Baynes Roy D. Director |
37,230 | $146.11 | $5,439,565 | 15,807 (Direct) |
View |
| 2020-08-07 Sale |
2020-08-11 6:20 pm |
Natera Inc. | NTRA | Baynes Roy D. Director |
1,300 | $53.47 | $69,513 | 15,230 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-11 Option Award |
2025-03-13 4:09 pm |
N/A 2035-03-10 |
Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2025-03-13 4:07 pm |
N/A 2033-04-10 |
Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2025-02-12 7:19 pm |
N/A 2034-12-17 |
Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director |
0 | $0 | 29,502 (Direct) |
View |
| 2025-02-06 Exercise |
2025-02-10 6:04 pm |
N/A 2027-05-17 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
10,000 | $0 | 31,000 (Direct) |
View |
| 2025-02-06 Exercise |
2025-02-10 6:04 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
10,000 | $17.44 | 31,000 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 9:15 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
92 | $0 | 15,899 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-23 8:36 pm |
N/A 2026-07-19 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
16,000 | $0 | 31,000 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-23 8:36 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
16,000 | $17.5 | 31,000 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-15 9:50 pm |
N/A 2029-05-23 |
Natera Inc. | NTRA | Baynes Roy D. Director |
37,230 | $0 | 15,807 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-15 9:50 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
22,000 | $22.83 | 15,807 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-15 9:50 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
15,230 | $24.42 | 15,807 (Direct) |
View |
| 2024-10-25 Option Award |
2024-10-29 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
124 | $0 | 15,807 (Direct) |
View |
| 2024-07-26 Option Award |
2024-07-30 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
143 | $0 | 15,683 (Direct) |
View |
| 2024-06-28 Option Award |
2024-07-02 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
2,964 | $0 | 15,540 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
26,000 | $0 | 50,500 (Direct) |
View |
| 2024-04-26 Option Award |
2024-04-30 8:35 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
169 | $0 | 12,576 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 8:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
215 | $63.79 | 12,407 (Direct) |
View |
| 2023-10-27 Option Award |
2023-10-31 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
322 | $42.6 | 12,192 (Direct) |
View |
| 2023-07-28 Option Award |
2023-08-01 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
264 | $48.48 | 11,870 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:05 pm |
N/A 2033-06-08 |
Natera Inc. | NTRA | Baynes Roy D. Director |
7,005 | $0 | 15,861 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
3,534 | $0 | 8,856 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:06 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
18,000 | $0 | 38,000 (Direct) |
View |
| 2023-04-14 Option Award |
2023-04-18 8:10 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
228 | $54.73 | 5,322 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 9:35 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
312 | $40.01 | 5,094 (Direct) |
View |
| 2022-10-14 Option Award |
2022-10-18 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
275 | $45.42 | 4,782 (Direct) |
View |
| 2022-07-08 Option Award(A) |
2022-09-02 8:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
344 | $0 | 4,507 (Direct) |
View |
| 2022-07-08 Option Award |
2022-07-12 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
344 | $36.31 | 344 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
52,000 | $0 | 75,000 (Direct) |
View |
| 2022-05-27 Option Award |
2022-06-01 9:05 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
10,602 | $0 | 10,602 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 9:45 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
1,307 | $0 | 4,163 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:18 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
12,000 | $0 | 29,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 7:03 pm |
N/A 2031-06-07 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
28,500 | $0 | 40,500 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-02 7:58 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
2,856 | $0 | 6,777 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 7:58 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
3,921 | $0 | 6,777 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:25 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
12,000 | $0 | 26,000 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 6:20 pm |
N/A 2028-09-13 |
Natera Inc. | NTRA | Baynes Roy D. Director |
1,300 | $0 | 15,230 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 6:20 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
1,300 | $24.42 | 15,230 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-17 5:43 pm |
N/A 2030-06-15 |
Atara Biotherapeutics Inc. | ATRA | Baynes Roy D. Director |
32,500 | $0 | 36,500 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 6:41 pm |
N/A N/A |
Natera Inc. | NTRA | Baynes Roy D. Director |
8,568 | $0 | 8,568 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 8:00 pm |
2021-05-15 2030-05-14 |
Retrophin Inc. | RTRX | Baynes Roy D. Director |
12,000 | $0 | 23,000 (Direct) |
View |